arrow
Return

Checkpoint Blockade

delete2021-09-10
delete2
delete
OA
AI
S
Spencer C. Wei *
J
James J. Mancuso
N
Naval Daver
J
James P. Allison *
DOI:10.1158/2643-3230.BCD-21-0130delete
deleteOriginal
deleteShare
deleteSave
Abstract

Abstract

En 中文
An emerging strategy to enhance the efficacy of immune checkpoint blockade in relapsed/refractory cancers is increasing immunogenic cell death via combination with cytotoxic therapies. Understanding the effects of cytotoxic and immunotherapeutic agents on immune cell populations will enable improved mechanism-based design of combination therapies to maximum efficacy and minimum toxicity.

Journal

Blood Cancer Discovery cover
Blood Cancer Discovery
IF:
11.5
Papers:
216
Citations:
1.7K

Organization

U
university of texas system
Scholars:
1.1K
Papers: 2.5K
Citations: 11.2W
U
ut md anderson cancer center
Scholars:
70
Papers: 21
Citations: 1.9W
Cited Papers

Cited Papers

The immunobiology of cancer immunosurveillance and immunoediting
errIMMUNITY
IF26.3
err2004-08-01
err2.6K
errOAAI
errDunn, GP; Old, LJ; Schreiber, RD
errShare
errSave
"X"-Rated Chromosomal Rendezvous
err2006-02-24
err0
PREAI
errLaura Carrel
errShare
errSave
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
errLEUKEMIA
IF13.4
err2021-05-05
err157
errOAAI
errDaver, Naval; Alotaibi, Ahmad S.; Bucklein, Veit; Subklewe, Marion
errShare
errSave
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML
err2020-12-10
err33
errOAAI
errShort, Nicholas J.; Rafei, Hind; Daver, Naval; Hwang, Hyunsoo; Ning, Jing; Jorgensen, Jeffrey L.; Kadia, Tapan M.; DiNardo, Courtney D.; Wang, Sa A.; Jabbour, Elias; Popat, Uday; Oran, Betul; Cortes, Jorge; Konopleva, Marina; Yilmaz, Musa; Issa, Ghayas C.; Kantarjian, Hagop; Ravandi, Farhad
errShare
errSave
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
err2019-10-21
err240
errOAAI
errWei, Spencer C.; Anang, Nana-Ama A. S.; Sharma, Roshan; Andrews, Miles C.; Reuben, Alexandre; Levine, Jacob H.; Cogdill, Alexandria P.; Mancuso, James J.; Wargo, Jennifer A.; Pe'er, Dana; Allison, James P.
errShare
errSave
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
err2021-09-10
err53
errOAAI
errZeidner, Joshua F.; Vincent, Benjamin G.; Ivanova, Anastasia; Moore, Dominic; McKinnon, Karen P.; Wilkinson, Alec D.; Mukhopadhyay, Rupkatha; Mazziotta, Francesco; Knaus, Hanna A.; Foster, Matthew C.; Coombs, Catherine C.; Jamieson, Katarzyna; Van Deventer, Hendrik; Webster, Jonathan A.; Prince, Gabrielle T.; DeZern, Amy E.; Smith, B. Douglas; Levis, Mark J.; Montgomery, Nathan D.; Luznik, Leo; Serody, Jonathan S.; Gojo, Ivana
errShare
errSave
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
err2018-09-04
err2.3K
errOAAI
errWei, Spencer C.; Duffy, Colm R.; Allison, James P.
errShare
errSave
no more